Today's Daily Dose brings you news about Aridis Pharma's collaboration with privately-held Mapp Biopharmaceutical; FDA approval for AZN/MRK's Lynparza for yet another indication; Axsome Therapeutics' continuing momentum; Sol-Gel's acne trial results; update on X4 Pharmaceuticals' Mavorixafor, and jail term for the Chinese scientist He Jiankui.
from RTT - Top Story https://ift.tt/36bXY6V
via IFTTT
from RTT - Top Story https://ift.tt/36bXY6V
via IFTTT
Comments
Post a Comment